As of 1:53pm ET
| -0.14 / -0.45%|
The 2 analysts offering 12-month price forecasts for Emergent BioSolutions Inc have a median target of 37.00, with a high estimate of 40.00 and a low estimate of 34.00. The median estimate represents a +19.59% increase from the last price of 30.94.
The current consensus among 2 polled investment analysts is to Buy stock in Emergent BioSolutions Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.